Grantee Signin

Can't access your account?  | New User?

<a href="https://www.biogen-international.com/en/regional-policies.html"target="_blank">Privacy Policy/Terms and Conditions</a> <br> <br> <a href="https://training.biogengrantsandgivingportal.com"target="_blank">Training Videos</a> <br> <br> <b>Please note:</b> Unless you are applying to Japan, Australia, New Zealand or Latin America, your application will be routed to the US office for triage and will be subject to the US Quarterly Application Submission windows for Grants & Donations (Open dates are April 15th, July 15th, & October 1st). Sponsorships are accepted on a rolling basis. <br> <br> <b>Critical Update for Hemophilia-related Applications & Awards:</b> <br>Biogen expects to complete the separation of Bioverativ into an independent, global biotechnology company focused on hemophilia and other rare blood disorders on February 1, 2017. <br> <b>In preparation for the transition to Bioverativ, beginning January 15th, Biogen will no longer accept applications for Hemophilia-related requests</b>. On February 1st, please go to<a href=”http://grantsandgiving.bioverativ.com/"> http://grantsandgiving.bioverativ.com/ </a> for instructions on how to request new funding support. All existing Awards / Agreements for Hemophilia-related activities and events that have not occurred or are still in progress will transfer to Bioverativ as of February 1, 2017. We apologize for the inconvenience this interruption may cause.